Identification of miRNA and mRNA expression profiles by PCR microarray in hepatitis B virus‑associated hepatocellular carcinoma

Cui,Xiong‑Wei; Qian,Zhi‑Ling; Li,Cong; Cui,Shi‑Chang

doi:10.3892/mmr.2018.9516

Identification of miRNA and mRNA expression profiles by PCR microarray in hepatitis B virus‑associated hepatocellular carcinoma

Authors:
- Xiong‑Wei Cui
- Zhi‑Ling Qian
- Cong Li
- Shi‑Chang Cui
View Affiliations

Affiliations: Interventional Center for Oncology, Beijing Youan Hospital, Capital Medical University, Beijing 100069, P.R. China
Published online on: September 27, 2018 https://doi.org/10.3892/mmr.2018.9516
Pages: 5123-5132

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to identify differentially expressed microRNAs (miRNAs) and mRNAs in hepatitis B virus‑associated hepatocellular carcinoma (HCC). A total of five HCC tissues and paired adjacent non‑tumor tissues were screened to identify the differentially expressed miRNAs and target mRNAs using polymerase chain reaction microarrays. The interaction between differential miRNA and mRNA expression was concurrently analyzed using bioinformatics methods. A total of 32 differentially expressed miRNAs (four upregulated miRNAs and 28 downregulated miRNAs) and 16 differentially expressed mRNAs (11 upregulated mRNAs and five downregulated mRNAs) were identified. Among these, upregulated hsa‑miRNA (miR)‑96‑5p and hsa‑miR‑18b‑5p suppressed their target mRNAs forkhead box O1 and MET transcriptional regulator MACC1 (MACC1). Downregulation of hsa‑miR‑199a‑5p led to upregulation of its target mRNAs, cyclin dependent kinase 4 and insulin like growth factor 2 (IGF2). The high‑level expression of IGF2 mRNA and cyclin E1 mRNA was due to the low‑level expression of hsa‑miR‑145‑5p, hsa‑miR‑181a‑5p, hsa‑miR‑199a‑5p and hsa‑miR‑223a‑3p, and hsa‑miR‑26a‑5p and hsa‑miR‑26b‑5p, respectively. The low‑level expression of coronin 1A mRNA and MACC1 mRNA was due to overexpression of hsa‑miR‑517a‑3p and hsa‑miR‑18a‑5p, and hsa‑miR‑18b‑5p, respectively. Numerous gene ontology terms were associated with oncogenesis. The most enriched pathways targeted by the dysregulated miRNAs and mRNAs were associated with cancer and oncogenesis pathways. The present data suggested that differential miRNA and mRNA expression is present in HCC. Thus, interactions between certain miRNAs and mRNAs may be involved in the pathogenesis of HCC.

View Figures

View References

1	Herszényi L and Tulassay Z: Epidemiology of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci. 14:249–258. 2010.PubMed/NCBI
2	El-Serag HB: Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 142:1264–1273. 2012. View Article : Google Scholar : PubMed/NCBI
3	Michielsen P and Ho E: Viral hepatitis B and hepatocellular carcinoma. Acta Gastroenterol Belg. 74:4–8. 2011.PubMed/NCBI
4	Li G, Cai G, Li D and Yin W: MicroRNAs and liver disease: Viral hepatitis, liver fibrosis and hepatocellular carcinoma. Postgrad Med J. 90:106–112. 2014. View Article : Google Scholar : PubMed/NCBI
5	Zamore PD and Haley B: Ribo-gnome: The big world of small RNAs. Science. 309:1519–1524. 2005. View Article : Google Scholar : PubMed/NCBI
6	Masaki T: MicroRNA and hepatocellular carcinoma. Hepatol Res. 39:751–752. 2009. View Article : Google Scholar : PubMed/NCBI
7	Aravalli RN, Steer CJ and Cressman EN: Molecular mechanisms of hepatocellular carcinoma. Hepatology. 48:2047–2063. 2008. View Article : Google Scholar : PubMed/NCBI
8	Nelson KM and Weiss GJ: MicroRNAs and cancer: Past, present, and potential future. Mol Cancer Ther. 7:3655–3660. 2008. View Article : Google Scholar : PubMed/NCBI
9	Ambros V: The functions of animal microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
10	Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
11	Esquela-Kerscher A and Slack FJ: Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006. View Article : Google Scholar : PubMed/NCBI
12	Djuranovic S, Nahvi A and Green R: miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay. Science. 336:237–240. 2012. View Article : Google Scholar : PubMed/NCBI
13	Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell1. 16:281–297. 2004. View Article : Google Scholar
14	Gu Z, Zhang C and Wang J: Gene regulation is governed by a core network in hepatocellular carcinoma. BMC Syst Biol. 6:322012. View Article : Google Scholar : PubMed/NCBI
15	Gao B, Ning S, Li J, Liu H, Wei W, Wu F, Tang Y, Feng Y, Li K and Zhang L: Integrated analysis of differentially expressed mRNAs and miRNAs between hepatocellular carcinoma and their matched adjacent normal liver tissues. Oncol Rep. 34:325–333. 2015. View Article : Google Scholar : PubMed/NCBI
16	Zeng L, Yu J, Huang T, Jia H, Dong Q, He F, Yuan W, Qin L, Li Y and Xie L: Differential combinatorial regulatory network analysis related to venous metastasis of hepatocellular carcinoma. BMC Genomics. 13 Suppl 8:S142012. View Article : Google Scholar : PubMed/NCBI
17	Wang D, Tan J, Xu Y, Tan X, Han M, Tu Y, Zhu Z, Zen J, Dou C and Cai S: Identification of MicroRNAs and target genes involvement in hepatocellular carcinoma with microarray data. Hepatogastroenterology. 62:378–382. 2015.PubMed/NCBI
18	Wang W, Zhao LJ, Tan YX, Ren H and Qi ZT: Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma. World J Gastroenterol. 18:5442–5453. 2012. View Article : Google Scholar : PubMed/NCBI
19	Han K, Li J, Zhao H, Liang P, Huang X, Zheng L, Li Y, Yang T and Wang L: Identification of the typical miRNAs and target genes in hepatocellular carcinoma. Mol Med Rep. 10:229–235. 2014. View Article : Google Scholar : PubMed/NCBI
20	He TL, Zheng KL, Li G, Song B and Zhang YJ: Identification of typical miRNAs and target genes in hepatocellular carcinoma by DNA microarray technique. Eur Rev Med Pharmacol Sci. 18:108–116. 2014.PubMed/NCBI
21	Wen LM, Wu WZ and Peng XC: Identifying significant pathways of hepatitis B virus-related hepatocellular carcinoma based on crosstalk and network pathways. Genet Mol Res. 15:2016. View Article : Google Scholar :
22	Li J, Shi W, Gao Y, Yang B, Jing X, Shan S, Wang Y and Du Z: Analysis of microRNA expression profiles in human hepatitis B virus-related hepatocellular carcinoma. Clin Lab. 59:1009–1015. 2013. View Article : Google Scholar : PubMed/NCBI
23	Thurnherr T, Mah WC, Lei Z, Jin Y, Rozen SG and Lee CG: Differentially expressed miRNAs in hepatocellular carcinoma target genes in the genetic information processing and metabolism pathways. Sci Rep. 28:200652016. View Article : Google Scholar
24	Katayama Y, Maeda M, Miyaguchi K, Nemoto S, Yasen M, Tanaka S, Mizushima H, Fukuoka Y, Arii S and Tanaka H: Identification of pathogenesis-related microRNAs in hepatocellular carcinoma by expression profiling. Oncol Lett. 4:817–823. 2012. View Article : Google Scholar : PubMed/NCBI
25	Zhang Y, Guo X, Xiong L, Yu L, Li Z, Guo Q, Li Z, Li B and Lin N: Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway. Mol Cancer. 13:2532014. View Article : Google Scholar : PubMed/NCBI
26	He D, Liu ZP, Honda M, Kaneko S and Chen L: Coexpression network analysis in chronic hepatitis B and C hepatic lesions reveals distinct patterns of disease progression to hepatocellular carcinoma. J Mol Cell Biol. 4:140–152. 2012. View Article : Google Scholar : PubMed/NCBI
27	Yang Y, Li D, Yang Y and Jiang G: An integrated analysis of the effects of microRNA and mRNA on esophageal squamous cell carcinoma. Mol Med Rep. 12:945–952. 2015. View Article : Google Scholar : PubMed/NCBI
28	Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, Nakajima Y and Ohnishi K: Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer. 56:918–928. 1985. View Article : Google Scholar : PubMed/NCBI
29	Bruix J and Sherman M: American Association for the Study of Liver Diseases: Management of hepatocellular carcinoma: An update. Hepatology. 53:1020–1022. 2011. View Article : Google Scholar : PubMed/NCBI
30	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
31	Leung WK, He M, Chan AW, Law PT and Wong N: Wnt/β-catenin activates MiR-183/96/182 expression in hepatocellular carcinoma that promotes cell invasion. Cancer Lett. 362:97–105. 2015. View Article : Google Scholar : PubMed/NCBI
32	Assal RA, El Tayebi HM, Hosny KA, Esmat G and Abdelaziz AI: A pleiotropic effect of the single clustered hepatic metasta miRs miR-96-5p and miR-182-5p on insulin-like growth factor II, insulin-like growth factor-1 receptor and insulin-like growth factor-binding protein-3 in hepatocellular carcinoma. Mol Med Rep. 12:645–650. 2015. View Article : Google Scholar : PubMed/NCBI
33	Baik SH, Lee J, Lee YS, Jang JY and Kim CW: ANT2 shRNA downregulates miR-19a and miR-96 through the PI3K/Akt pathway and suppresses tumor growth in hepatocellular carcinoma cells. Exp Mol Med. 25:e2222016. View Article : Google Scholar
34	Chen Y, Dong X, Yu D and Wang X: Serum miR-96 is a promising biomarker for hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Int J Clin Exp Med. 8:18462–18468. 2015.PubMed/NCBI
35	Komatsu S, Ichikawa D, Takeshita H, Morimura R, Hirajima S, Tsujiura M, Kawaguchi T, Miyamae M, Nagata H, Konishi H, et al: Circulating miR-18a: A sensitive cancer screening biomarker in human cancer. In Vivo. 28:293–297. 2014.PubMed/NCBI
36	Tan W, Li Y, Lim SG and Tan TM: miR-106b-25/miR-17-92 clusters: Polycistrons with oncogenic roles in hepatocellular carcinoma. World J Gastroenterol. 20:5962–5972. 2014. View Article : Google Scholar : PubMed/NCBI
37	Murakami Y, Tamori A, Itami S, Tanahashi T, Toyoda H, Tanaka M, Wu W, Brojigin N, Kaneoka Y, Maeda A, et al: The expression level of miR-18b in hepatocellular carcinoma is associated with the grade of malignancy and prognosis. BMC Cancer. 13:992013. View Article : Google Scholar : PubMed/NCBI
38	Al-Kafaji G, Al-Naieb ZT and Bakhiet M: Increased oncogenic microRNA-18a expression in the peripheral blood of patients with prostate cancer: A potential novel non-invasive biomarker. Oncol Lett. 11:1201–1206. 2016. View Article : Google Scholar : PubMed/NCBI
39	Huang JY, Zhang K, Chen DQ, Chen J, Feng B, Song H, Chen Y, Zhu Z, Lu L, De W, et al: MicroRNA-451: Epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma. Oncotarget. 6:18613–18630. 2015.PubMed/NCBI
40	Liu X, Zhang A, Xiang J, Lv Y and Zhang X: miR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway. Oncol Rep. 36:1385–1392. 2016. View Article : Google Scholar : PubMed/NCBI
41	Han Y, Kuang Y, Xue X, Guo X, Li P, Wang X, Guo X, Yuan B, Zhi Q and Zhao H: NLK, A novel target of miR-199a-3p, functions as a tumor suppressor in colorectal cancer. Biomed Pharmacother. 68:497–505. 2014. View Article : Google Scholar : PubMed/NCBI
42	Li SQ, Wang ZH, Mi XG, Liu L and Tan Y: MiR-199a/b-3p suppresses migration and invasion of breast cancer cells by downregulating PAK4/MEK/ERK signaling pathway. IUBMB Life. 67:768–777. 2015. View Article : Google Scholar : PubMed/NCBI
43	Zhou M, Wang S, Hu L, Liu F, Zhang Q and Zhang D: miR-199a-5p suppresses human bladder cancer cell metastasis by targeting CCR7. BMC Urol. 16:642016. View Article : Google Scholar : PubMed/NCBI
44	Byrnes KA, Phatak P, Mansour D, Xiao L, Zou T, Rao JN, Turner DJ, Wang JY and Donahue JM: Overexpression of miR-199a-5p decreases esophageal cancer cell proliferation through repression of mitogen-activated protein kinase kinase kinase-11 (MAP3K11). Oncotarget. 7:8756–8770. 2016. View Article : Google Scholar : PubMed/NCBI
45	Song G, Zeng H, Li J, Xiao L, He Y, Tang Y and Li Y: miR-199a regulates the tumor suppressor mitogen-activated protein kinase kinase kinase 11 in gastric cancer. Biol Pharm Bull. 33:1822–1827. 2010. View Article : Google Scholar : PubMed/NCBI
46	Shen Q, Cicinnati VR, Zhang X, Iacob S, Weber F, Sotiropoulos GC, Radtke A, Lu M, Paul A, Gerken G and Beckebaum S: Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion. Mol Cancer. 9:2272010. View Article : Google Scholar : PubMed/NCBI
47	Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong Q, Qin L, Wu X, Zheng Y, Yang Y, et al: Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell. 19:232–243. 2011. View Article : Google Scholar : PubMed/NCBI
48	Liu L, Lu L, Zheng A, Xie J, Xue Q, Wang F, Wang X, Zhou H, Tong X, Li Y, et al: MiR-199a-5p and let-7c cooperatively inhibit migration and invasion by targeting MAP4K3 in hepatocellular carcinoma. Oncotarget. 8:13666–13677. 2017.PubMed/NCBI
49	Amr KS, Ezzat WM, Elhosary YA, Hegazy AE, Fahim HH and Kamel RR: The potential role of miRNAs 21 and 199-a in early diagnosis of hepatocellular carcinoma. Gene. 575:66–70. 2016. View Article : Google Scholar : PubMed/NCBI
50	Kamel RR, Amr KS, Afify M, Elhosary YA, Hegazy AE, Fahim HH and Ezzat WM: Relation between microRNAs and Apoptosis in Hepatocellular Carcinoma. Maced J Med Sci. 4:31–37. 2016. View Article : Google Scholar
51	Kanehisa M and Goto S: KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30. 2000. View Article : Google Scholar : PubMed/NCBI
52	Lovering RC, Camon EB, Blake JA and Diehl AD: Access to immunology through the Gene Ontology. Immunology. 125:154–160. 2008. View Article : Google Scholar : PubMed/NCBI
53	Pinyol R, Nault JC, Quetglas IM, Zucman-Rossi J and Llovet JM: Molecular profiling of liver tumors: Classification and clinical translation for decision making. Semin Liver Dis. 34:363–375. 2014. View Article : Google Scholar : PubMed/NCBI
54	Shanbhogue AK, Prasad SR, Takahashi N, Vikram R and Sahani DV: Recent advances in cytogenetics and molecular biology of adult hepatocellular tumors: Implications for imaging and management. Radiology. 258:673–693. 2011. View Article : Google Scholar : PubMed/NCBI